| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
Biopsy and implantation of the seminal vesicles
DOI: 10.1016/j.brachy.2011.12.008
Abstract: Purpose: To describe the technique and outcomes of seminal vesicle biopsy (SVB) and permanent implantation in patients with T3b prostate cancer. Methods and Materials: Intermediate- and high...
|
Nelson N. Stone,
Vassilios M. Skouteris,
Richard G. Stock
|
Short communication
(In Press Corrected Proof)
|
06 February 2012 |
|
Is there any advantage to three-dimensional planning for vaginal cuff brachytherapy?
DOI: 10.1016/j.brachy.2011.12.009
Abstract: Purpose: To evaluate whether the three-dimensional (3D) CT-based high-dose rate planning for vaginal cuff brachytherapy offers any advantage over the 2D orthogonal film-based library plans f...
|
Hyun Kim,
Hayeon Kim,
Christopher Houser,
Sushil Beriwal
|
Full-length article
(In Press Corrected Proof)
|
03 February 2012 |
|
Radioactive seed migration after transperineal interstitial prostate brachytherapy and associated development of small-cell lung cancer
DOI: 10.1016/j.brachy.2011.12.003
Abstract: Purpose: We report a case of lung carcinoma developing in the location of a migrated prostate brachytherapy seed. Methods and Materials: A 57-year-old male nonsmoker was originally diagnosed...
|
William C. Chen,
Jerald Katcher,
Carlos Nunez,
Ali M. Tirgan,
Rodney J. Ellis
et al.
|
Short communication
(In Press Corrected Proof)
|
16 January 2012 |
|
Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy
DOI: 10.1016/j.brachy.2011.11.005
Abstract: Purpose: The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the ...
|
Javier Vijande,
Facundo Ballester,
Zoubir Ouhib,
Domingo Granero,
M. Carmen Pujades-Claumarchirant,
Jose Perez-Calatayud
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Practical steps for establishing ocular plaque therapy in developing countries
DOI: 10.1016/j.brachy.2011.12.002
Abstract: Introduction: Retinoblastoma and uveal melanoma are the most common ocular tumors in children and adults, respectively. Enucleation and external beam radiation therapy are integral in the ma...
|
Imad Jaradat,
Layth Mula-Hussain,
Shada Wadi-Ramahi,
Abdelatif Al-Mousa,
Ahmed Salem,
Inad Haddadin,
Mustafa Meheyar,
Saamir Kharma,
Khaleel Rawashdeh,
Iyad Sultan,
Ghadeer Abdeen,
Ibrahim Qaddoumi,
Ibrahim Nawaiseh
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Reirradiation of paraaortic lymph node metastasis by brachytherapy with hyaluronate injection via paravertebral approach: With DVH comparison to IMRT
DOI: 10.1016/j.brachy.2011.12.004
Abstract: Purpose/Introduction: To safely irradiate retroperitoneal targets as paraaortic lymph node by separating abdominal at-risk organs from the target during irradiation, we created a percutaneou...
|
Kazushi Kishi,
Tetsuo Sonomura,
Shintaro Shirai,
Yasutaka Noda,
Morio Sato,
Hitoshi Ikushima,
Ryoong-Jin Oh
et al.
|
Short communication
(In Press Corrected Proof)
|
30 December 2011 |
|
Comparison of prostate volume, shape, and contouring variability determined from preimplant magnetic resonance and transrectal ultrasound images
DOI: 10.1016/j.brachy.2011.11.004
Abstract: Purpose: To compare preimplant prostate contours and contouring variability between magnetic resonance (MR) and transrectal ultrasound images. Methods and Materials: Twenty-three patients we...
|
Derek Liu,
Nawaid Usmani,
Sunita Ghosh,
Wafa Kamal,
John Pedersen,
Nadeem Pervez,
Don Yee,
Brita Danielson,
Albert Murtha,
John Amanie,
Ron S. Sloboda
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
Prostate brachytherapy seed migration to a left varicocele
DOI: 10.1016/j.brachy.2011.11.003
Abstract: Purpose: To report a rare case of seed migration to a left varicocele after transperineal interstitial prostate brachytherapy with loose iodine-125 (125I) seeds. Methods and Materials: A 73-...
|
Akitomo Sugawara,
Jun Nakashima,
Etsuo Kunieda,
Hirohiko Nagata,
Ryuichi Mizuno,
Satoshi Seki,
Yutaka Shiraishi,
Ryuichi Kouta,
Mototsugu Oya,
Naoyuki Shigematsu
et al.
|
Short communication
(In Press Corrected Proof)
|
23 December 2011 |
|
Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer
DOI: 10.1016/j.brachy.2011.12.001
Abstract: Purpose: To compare the dose distribution characteristics of stereotactic body radiotherapy (SBRT) with intracavitary high-dose-rate (HDR) brachytherapy in patients with cervical carcinoma. ...
|
Mustafa Cengiz,
Ali Dogan,
Gokhan Ozyigit,
Ertugrul Erturk,
Ferah Yildiz,
Ugur Selek,
Sukran Ulger,
Fatma Colak,
Faruk Zorlu
et al.
|
Full-length article
(In Press Corrected Proof)
|
23 December 2011 |
|
Initial clinical experience with multilumen brachytherapy catheters for accelerated partial breast irradiation
DOI: 10.1016/j.brachy.2011.11.001
Abstract: Purpose: To review the initial experience of three institutions using multilumen catheters to deliver accelerated partial breast irradiation (APBI) and evaluate dosimetric improvements. Meth...
|
Chirag Shah,
Mihai Ghilezan,
Douglas Arthur,
John B. Wilkinson,
Martin Keisch,
Peter Chen,
Frank A. Vicini
et al.
|
Full-length article
(In Press Corrected Proof)
|
23 December 2011 |
|
A comparison of the impact of isotope (125I vs. 103Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer
DOI: 10.1016/j.brachy.2011.11.002
Abstract: Purpose: To compare biochemical outcomes and morbidity associated with iodine-125 (125I) and palladium-103 (103Pd) brachytherapy as part of combined modality therapy for clinically localized...
|
Marisa A. Kollmeier,
Xin Pei,
Ece Algur,
Yoshiya Yamada,
Brett W. Cox,
Gil’ad N. Cohen,
Marco Zaider,
Michael J. Zelefsky
et al.
|
Full-length article
(In Press Corrected Proof)
|
23 December 2011 |
|
Is prostate-specific antigen percentage decrease predictive of clinical outcome after permanent iodine-125 interstitial brachytherapy for prostate cancer?
DOI: 10.1016/j.brachy.2011.08.008
Abstract: Objective: To determine the usefulness of prostate-specific antigen (PSA) percentage (vs. pretreatment value assumed as 100%) in prediction of biochemical relapse, after iodine-125 (125I) pe...
|
Mauro Paoluzzi,
Marcello Mignogna,
Elena Lorenzini,
Francesca Valent,
Nicola Fontana,
Novello Pinzi,
Fabrizio Repetti,
Roberto Ponchietti
et al.
|
Full-length article
(In Press Corrected Proof)
|
05 December 2011 |
|
The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone
DOI: 10.1016/j.brachy.2011.09.007
Abstract: Purpose: To compare the outcomes of combined treatment of choroidal melanoma with ruthenium brachytherapy (BT) simultaneously with transpupillary thermotherapy (TTT) and treatment with BT al...
|
Andrey A. Yarovoy,
Dzhavid A. Magaramov,
Evgeniya S. Bulgakova
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
Experimental characterization of the dosimetric properties of a newly designed I-Seed model AgX100 125I interstitial brachytherapy source
DOI: 10.1016/j.brachy.2011.08.009
Abstract: Purpose: To measure the dosimetric properties of the Model AgX100 125I source for interstitial brachytherapy. Methods and Materials: The photon energy spectrum emitted by the AgX100 source w...
|
Zhe Chen,
Paul Bongiorni,
Ravinder Nath
|
Short communication
(In Press Corrected Proof)
|
21 November 2011 |
|
Tumor bed-to-skin distance using accelerated partial-breast irradiation with the strut-adjusted volume implant device
DOI: 10.1016/j.brachy.2011.09.009
Abstract: Purpose: Because of the risk of skin toxicity with single dwell position, single-lumen brachytherapy devices are sometimes contraindicated for tumor cavities 5–7mm from the skin surface. We ...
|
Brandon Fisher,
Larry Daugherty,
Talha Shaikh,
Jay Reiff,
Dan Perlingiero,
Fiori Alite,
Luther Brady,
Lydia Komarnicky
et al.
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers
DOI: 10.1016/j.brachy.2011.09.006
Abstract: Purpose: The main purpose of the study was to assess the results of high-dose-rate brachytherapy (HDRBT) and pulsed-dose-rate brachytherapy (PDRBT) in the palliative treatment of patients wi...
|
Anna Bartochowska,
Małgorzata Wierzbicka,
Janusz Skowronek,
Małgorzata Leszczyńska,
Witold Szyfter
et al.
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
Image-guided vulvovaginal interstitial brachytherapy in the treatment of primary and recurrent gynecological malignancies
DOI: 10.1016/j.brachy.2011.08.002
Abstract: Purpose: Evaluation of interstitial high-dose-rate brachytherapy (HDRB) to the vulvovaginal region both alone and in combination with external beam radiotherapy (EBRT) for primary or recurre...
|
Paulo B. De Ieso,
Vinod Mullassery,
Raj Shrimali,
Gerry Lowe,
Linda Bryant,
Peter J. Hoskin
et al.
|
Full-length article
(In Press Corrected Proof)
|
13 October 2011 |
|
A comparison of the biological effective dose of 50-kV electronic brachytherapy with 192Ir high-dose-rate brachytherapy for vaginal cuff irradiation
DOI: 10.1016/j.brachy.2011.08.004
Abstract: Purpose: Advantages for electronic brachytherapy (EBT) of the vaginal cuff include decreased physical dose to the bladder and rectum. Here we compare 192Ir with EBT using biological effectiv...
|
Paul Rava,
Tomas Dvorak,
Robert J. Markelewicz,
Jessica R. Hiatt,
Edward S. Sternick,
Stephanie G. MacAusland,
Kathryn Huber,
David E. Wazer,
Jaroslaw T. Hepel
et al.
|
Full-length article
(In Press Corrected Proof)
|
13 October 2011 |
|
Quantitative evaluation of lower urinary tract symptoms using a visual analog scale in men undergoing permanent brachytherapy
DOI: 10.1016/j.brachy.2011.08.007
Abstract: Purpose: A previous study showed that a visual analog scale (VAS) that measures quality of life (QOL) in relation to each of the seven items on the International Prostate Symptom Score (IPSS...
|
Koji Okihara,
Osamu Ukimura,
Soh Ushijima,
Kazumi Kamoi,
Tsuyoshi Iwata,
Kana Kobayashi,
Yasuyuki Naitoh,
Hideya Yamazaki,
Akihiro Kawauchi,
Tsuneharu Miki
et al.
|
Full-length article
(In Press Corrected Proof)
|
13 October 2011 |
|
Semiautomatic segmentation for prostate brachytherapy: Dosimetric evaluation
DOI: 10.1016/j.brachy.2011.07.007
Abstract: Purpose: To demonstrate that manual prostate segmentation in transrectal ultrasound images can be replaced with semiautomatic segmentation. Methods and Materials: Semiautomatic segmentation ...
|
S. Sara Mahdavi,
Ingrid Spadinger,
Nick Chng,
Septimiu E. Salcudean,
William James Morris
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 September 2011 |
|
Two-step transurethral surgery of the prostate and permanent implant brachytherapy for patients with lower urinary tract symptoms and low- to intermediate-risk prostate cancer
DOI: 10.1016/j.brachy.2011.08.006
Abstract: Purpose: Prostate brachytherapy is an increasingly used treatment option for low- to intermediate-risk prostate cancer (PCa). However, patients with preexisting lower urinary tract symptoms ...
|
Allie N. Ivanowicz,
Carolyn M. Wakeman,
Ryan T. Hubbard,
William B. DeVoe,
Michael R. Haake,
Chris M. Teigland
et al.
|
Full-length article
(In Press Corrected Proof)
|
22 September 2011 |
|
Urethra low-dose tunnels: Validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy
DOI: 10.1016/j.brachy.2011.07.009
Abstract: Purpose: Urethral dose is related to severity of genitourinary toxicity in patients treated with brachytherapy for prostate cancer. This work describes a dose planning method that uses inver...
|
J. Adam M. Cunha,
Jean Pouliot,
Vivian Weinberg,
Alice Wang-Chesebro,
Mack Roach,
I-Chow Hsu
et al.
|
Full-length article
(In Press Corrected Proof)
|
22 September 2011 |
|
Globalization, implantation, cremation…Oh, my!
DOI: 10.1016/j.brachy.2011.08.001
When speaking about the flattening of the world, former Secretary-General of the United Nations and Nobel Peace Prize winner, Kofi Annan, once stated, “It has been said that arguing against globalizat...
|
Lawrence T. Dauer
|
Editorial
(In Press Corrected Proof)
|
19 September 2011 |
|
Deaths within 12 months after 125I implantation for brachytherapy of prostate cancer: An investigation of radiation safety issues in Japan (2003–2010)
DOI: 10.1016/j.brachy.2011.06.009
Abstract: Purpose: The International Commission on Radiological Protection recommends removing the prostate before cremation if death occurs within 12 months after 125I brachytherapy. However, the inc...
|
Takefumi Satoh,
Hidetoshi Yamanaka,
Takashi Yamashita,
Manabu Aoki,
Shin Egawa,
Shiro Saito,
Suoh Sakata,
Hitoshi Shibuya,
Nobuyuki Sugiura,
Yutaka Takahashi,
Tetsuo Nishimura,
Tatsuji Hamada,
Tsuneharu Miki,
Atsunori Yorozu,
Takushi Dokiya
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 September 2011 |
|
Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience
DOI: 10.1016/j.brachy.2011.08.003
Abstract: Purpose: To identify predictors of biochemical tumor control and present an updated prognostic nomogram for patients with clinically localized prostate cancer treated with brachytherapy. Met...
|
Michael J. Zelefsky,
Joanne F. Chou,
Xin Pei,
Yoshiya Yamada,
Marisa Kollmeier,
Brett Cox,
Zhigang Zhang,
Michael Schechter,
Gil’ad N. Cohen,
Marco Zaider
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 September 2011 |
|
Three-year clinical outcome using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI): Improving radiation standards for the optimal application of APBI
DOI: 10.1016/j.brachy.2011.07.008
Abstract: Purpose: We reviewed our institution’s 3-year clinical experience in treating patients with the Contura multilumen balloon (SenoRx, Inc., Aliso Viejo, CA) breast brachytherapy catheter to de...
|
Philip Z. Israel,
Angela Robbins,
Paulomi Shroff,
Sheree Brown,
Mark McLaughlin,
Keith Pope
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 September 2011 |
|
High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results
DOI: 10.1016/j.brachy.2011.05.003
Abstract: Purpose: To evaluate the technical feasibility, acute and late genitourinary (GU) toxicity, and gastrointestinal toxicity after high-dose-rate (HDR) brachytherapy as monotherapy in one fract...
|
Pedro J. Prada,
Isabel Jimenez,
Herminio González-Suárez,
José Fernández,
Covadonga Cuervo-Arango,
Lucia Mendez
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 September 2011 |
|
Timing of postseed imaging influences rectal dose–volume parameters for cesium-131 prostate seed implants
DOI: 10.1016/j.brachy.2011.07.004
Abstract: Purpose: To study the influence of timing of postseed implant imaging on rectal dose–volume parameters for cesium-131 (131Cs) seed prostate implants. Methods and Materials: Fifteen patients ...
|
Ravindra Yaparpalvi,
Raquibul Hannan,
Evan Landau,
Norman Kahan,
William Bodner,
Hsiang-Chi Kuo,
Lloyd Minsky,
Keyur J. Mehta,
Madhur K. Garg,
Shalom Kalnicki,
Chandan Guha
et al.
|
Full-length article
(In Press Corrected Proof)
|
25 August 2011 |
|
Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: Clinical outcomes and dose–volume histogram analysis
DOI: 10.1016/j.brachy.2011.06.005
Abstract: Purpose: To present clinical outcomes and dose–volume histogram parameters of three-dimensional image–based high-dose-rate interstitial brachytherapy (HDR-ISBT) in patients with primary or r...
|
Isabelle Thibault,
Marie-Claude Lavallée,
Sylviane Aubin,
Nathalie Laflamme,
Éric Vigneault
et al.
|
Full-length article
(In Press Corrected Proof)
|
22 August 2011 |
|
Higher percentage of positive biopsy cores and Gleason score are associated with a greater degree of prostate gland shrinkage after neoadjuvant cytoreductive therapy
DOI: 10.1016/j.brachy.2011.06.004
Abstract: Purpose: To determine whether adverse pathologic features, including tumor grade and percent positive biopsy (PPB) cores, predict for prostate size reduction after neoadjuvant cytoreductive ...
|
Nathan Bittner,
Gregory S. Merrick,
Wayne M. Butler,
Robert W. Galbreath,
Richard L. Anderson,
Edward Adamovich,
Kent E. Wallner
et al.
|
Full-length article
(In Press Corrected Proof)
|
08 August 2011 |
|
Reirradiation of prostate cancer with rectum preservation: Eradicative high-dose-rate brachytherapy with natural type hyaluronate injection
DOI: 10.1016/j.brachy.2011.06.006
Abstract: Introduction: Reirradiation of locally recurrent prostate cancer after radiotherapy is limited because of its toxicity to the rectum that is closely adjacent to the prostate. To solve geomet...
|
Kazushi Kishi,
Morio Sato,
Shintaro Shirai,
Tetsuo Sonomura,
Ryuichi Yamama
et al.
|
Short communication
(In Press Corrected Proof)
|
08 August 2011 |
|
Interfraction accumulation of seroma during accelerated partial breast irradiation: Preliminary results of a prospective study
DOI: 10.1016/j.brachy.2011.06.007
Abstract: Purpose: To quantify and characterize the process of seroma accumulation during accelerated partial breast irradiation using multicatheter balloon brachytherapy. Materials and Methods: Twent...
|
Aashish D. Bhatt,
John B. Crew,
Geetika Bhatt,
Robert R. Johnson,
Keith T. Sowards,
Jianmin Pan,
Anthony E. Dragun
et al.
|
Full-length article
(In Press Corrected Proof)
|
08 August 2011 |
|
A comparison of brachytherapy techniques for partial breast irradiation
DOI: 10.1016/j.brachy.2011.06.001
Abstract: Accelerated partial breast irradiation has emerged as an important treatment option for select patients with early-stage breast cancer. Numerous techniques for the delivery of accelerated pa...
|
Jaroslaw T. Hepel,
David E. Wazer
|
Review article
(In Press Corrected Proof)
|
05 August 2011 |
|
Objective automated assessment of time trends in prostate edema after 125I implantation
DOI: 10.1016/j.brachy.2011.06.003
Abstract: Purpose: To present an objective automated method to determine time trends in prostatic edema resulting from iodine-125 brachytherapy. Methods and Materials: We followed 20 patients, implant...
|
Hendrik Westendorp,
Rob Kattevilder,
Arie van ’t Riet,
André W. Minken,
Tonnis T. Nuver,
Jos J. Immerzeel,
Carel J. Hoekstra
et al.
|
Full-length article
(In Press Corrected Proof)
|
04 August 2011 |
|
Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the 125I I-Seed AgX100 source model
DOI: 10.1016/j.brachy.2011.06.002
Abstract: Purpose: The purpose of this study was to determine the dosimetric parameters of the AgX100, a new 125I brachytherapy seed model, using Monte Carlo (MC) simulations according to the protocol...
|
Firas Mourtada,
Justin Mikell,
Geoffrey Ibbott
|
Full-length article
(In Press Corrected Proof)
|
04 August 2011 |
|
Rectal toxicity and rectal dosimetry in low-dose-rate iodine-125 permanent prostate implants: A long-term study in 1006 patients
DOI: 10.1016/j.brachy.2011.05.007
Abstract: Objective: To describe the acute and late rectal toxicity in 1006 prostate brachytherapy patients implanted 1998–2003. To determine whether rectal dose–volume histogram as well as patient an...
|
Mira Keyes,
Ingrid Spadinger,
Mitchell Liu,
Tom Pickles,
Howard Pai,
Amy Hayden,
Veronika Moravan,
Ross Halperin,
Michael McKenzie,
Winkle Kwan,
Alexander Agranovic,
Vince Lapointe,
W. James Morris
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 July 2011 |
|
Experimental measurements and Monte Carlo simulations of dose perturbation around a nonradioactive brachytherapy seed due to 6- and 18-MV photons
DOI: 10.1016/j.brachy.2011.05.010
Abstract: Purpose: Radioactive seeds used in permanent prostate brachytherapy are composed of high-Z metals and may exceed 100 in a patient. If supplemental external beam treatment is administered aft...
|
James Paul Steinman,
Mohammad Bakhtiari,
Harish Kumar Malhotra
|
Full-length article
(In Press Corrected Proof)
|
08 July 2011 |
|
Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy
DOI: 10.1016/j.brachy.2011.05.011
Abstract: Purpose: To evaluate patient characteristics and dosimetric parameters that predict biochemical failure (BCF) after real-time planned low-dose-rate prostate brachytherapy. Methods and Materi...
|
Wilhelm Lubbe,
Randi Cohen,
Navesh Sharma,
Karen Ruth,
Ruth Peters,
Jinsheng Li,
Mark Buyyounouski,
Alexander Kutikov,
David Chen,
Robert Uzzo,
Eric Horwitz
et al.
|
Full-length article
(In Press Corrected Proof)
|
04 July 2011 |
|
Four-year results using balloon-based brachytherapy to deliver accelerated partial breast irradiation with a 2-day dose fractionation schedule
DOI: 10.1016/j.brachy.2011.05.012
Abstract: Purpose: We present 4-year results from a Phase I/II trial using balloon-based brachytherapy to deliver accelerated partial breast irradiation in 2 days. Materials/Methods: Forty-five patien...
|
J. Ben Wilkinson,
Alvaro A. Martinez,
Peter Y. Chen,
Mihai I. Ghilezan,
Michelle F. Wallace,
Inga S. Grills,
Chirag S. Shah,
Christina K. Mitchell,
Evelyn Sebastian,
Amy S. Limbacher,
Pamela R. Benitez,
Eric A. Brown,
Frank A. Vicini
et al.
|
Full-length article
(In Press Corrected Proof)
|
04 July 2011 |
|
Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer
DOI: 10.1016/j.brachy.2011.05.008
Abstract: Purpose: To compare the efficacy and the incidence of complications of high-dose-rate (HDR) and low-dose-rate (LDR) intraluminal brachytherapy (IBT) boost after external beam radiation thera...
|
Tomoaki Tamaki,
Hitoshi Ishikawa,
Takeo Takahashi,
Yoshio Tamaki,
Yoshizumi Kitamoto,
Masahiko Okamoto,
Shin-ei Noda,
Hiroyuki Katoh,
Katsuyuki Shirai,
Hideyuki Sakurai,
Takashi Nakano
et al.
|
Full-length article
(In Press Corrected Proof)
|
23 June 2011 |
|
Relationship between prostate-specific antigen bounce body fat distribution and body mass index in permanent seed brachytherapy for prostate cancer
DOI: 10.1016/j.brachy.2011.05.009
Abstract: Purpose: To analyze the influence of body mass index (BMI) and adipose tissue distribution on prostate-specific antigen (PSA) bounce after iodine-125 prostate brachytherapy. Methods and Mate...
|
Guila Delouya,
Daniel Taussky,
Catherine Ran Ji,
Marie-Pierre Sylvestre,
David Donath
et al.
|
Full-length article
(In Press Corrected Proof)
|
23 June 2011 |
|
Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer
DOI: 10.1016/j.brachy.2011.05.004
Abstract: Objective: To compare the biologic equivalence in terms of local control and toxicity of a short course of high-dose-rate intravaginal brachytherapy alone (IVBa) delivered over five consecut...
|
Miren Gaztañaga,
Mauricio Cambeiro,
Elena Villafranca,
Meritxell Vila,
Matías Jurado,
Marta Moreno,
Rafael Martínez-Monge
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 June 2011 |
|
Dosimetric effect of interfractional needle displacement in prostate high-dose-rate brachytherapy
DOI: 10.1016/j.brachy.2011.05.006
Abstract: Purpose: To quantify the dosimetric deviations that would arise from delivering subsequent prostate high-dose-rate fractions with only needle readjustment and no replanning after the first f...
|
Nataliya Kovalchuk,
Keith M. Furutani,
O. Kenneth Macdonald,
Thomas M. Pisansky
|
Full-length article
(In Press Corrected Proof)
|
20 June 2011 |
|
3D image-based HDR interstitial brachytherapy for vaginal cancer
DOI: 10.1016/j.brachy.2011.05.005
Abstract: Purpose: To evaluate dosimetric and clinical outcomes of three-dimensional (3D) image–based high-dose-rate (HDR) interstitial brachytherapy (HDRB) in patients with vaginal cancers. Methods a...
|
Sushil Beriwal,
Jean-Claude M. Rwigema,
Emma Higgins,
Hayeon Kim,
Chris Houser,
Paniti Sukumvanich,
Alexander Olawaiye,
Scott Richard,
Joseph L. Kelley,
Robert P. Edwards,
Thomas C. Krivak
et al.
|
Full-length article
(In Press Corrected Proof)
|
13 June 2011 |
|
Comparison of cellular damage response to low-dose-rate 125I seed irradiation and high-dose-rate gamma irradiation in human lung cancer cells
DOI: 10.1016/j.brachy.2011.05.002
Abstract: Purpose: To investigate the difference of cellular response between low-dose-rate (LDR) 125I seed irradiation and high-dose-rate (HDR) γ-irradiation in human lung cancer cells. Methods and M...
|
Honghong Chen,
Yizhong Bao,
Lei Yu,
Rongfei Jia,
Wenying Cheng,
Chunlin Shao
et al.
|
Full-length article
(In Press Corrected Proof)
|
13 June 2011 |
|
Whitmore, Henschke, and Hilaris: The reorientation of prostate brachytherapy (1970–1987)
DOI: 10.1016/j.brachy.2011.03.003
Abstract: Purpose: Urologists had performed prostate brachytherapy for decades before New York’s Memorial Hospital retropubic program. This paper explores the contribution of Willet Whitmore, Ulrich H...
|
Jesse N. Aronowitz
|
Short communication
(In Press Corrected Proof)
|
03 June 2011 |